- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Locally Advanced Unresectable Pancreatic Adenocarcinoma in India
Total 28 results
-
AstraZenecaActive, not recruitingMetastatic Urothelial Cancer | Unresectable Locally Advanced Urothelial CancerUnited States, Italy, Spain, Canada, Hungary, Poland, Argentina, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, India, Japan, Philippines, Russian Federation, China, Taiwan, Israel, Australia, Bulgaria
-
AB ScienceCompletedLocally Advanced or Metastatic Pancreatic CancerFrance, Belgium, Greece, India, Russian Federation, Slovakia, Tunisia, Ukraine
-
CytRxUnknownUnresectable Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Locally Advanced Soft Tissue SarcomaUnited States, Australia, Russian Federation, Hungary, India, Romania, Ukraine
-
Mahatma Gandhi Institute of Medical SciencesRecruitingLocally Advanced Malignant NeoplasmIndia
-
Tata Memorial HospitalTerminatedLocally Advanced Breast Cancer and Large Operable Breast CancerIndia
-
Merck KGaA, Darmstadt, GermanyMerck Ltd., IndiaTerminatedUnresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck | LA SCCHNIndia
-
Bharat Serums and Vaccines LimitedCompletedAdvanced Prostate AdenocarcinomaIndia
-
Tata Memorial HospitalCompletedPancreatic Neoplasms Malignant | Malignant Neoplasm of Gall Bladder Non-resectableIndia
-
Hoffmann-La RocheCompletedHER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast CancerIndia
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Postgraduate Institute of Medical Education and...RecruitingHepatic Carcinoma Malignant Primary Non-ResectableIndia
-
Swami Rama Cancer Hospital and Research InstituteUnknownLung Cancer | Squamous Cell Carcinoma of the Lung | Locally Advanced and Metastatic Squamous Cell Carcinoma of the LungIndia
-
Onconova Therapeutics, Inc.Academic GI Cancer Consortium (AGICC)CompletedMetastatic Pancreatic AdenocarcinomaUnited States, India, Russian Federation, Hungary, Ukraine
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerUnited States, Spain, Denmark, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Brazil, Canada, China, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, India, Poland, Sweden, Italy
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, China, Italy, Argentina, Jordan, Mexico, Brazil, Germany, Portugal, Thailand, Turkey, United Kingdom, Kenya, Spain, Hungary, Colombia, India, Oman, Poland, Uganda, United Arab...
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
BiocadRecruitingMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma Metastatic | Melanoma Unresectable | Melanoma AdvancedIndia, Russian Federation, Belarus
-
Hoffmann-La RocheRecruitingUnresectable Hepatocellular CarcinomaCanada, France, Korea, Republic of, China, Japan, Spain, Belgium, Croatia, Brazil, Austria, Italy, Costa Rica, Germany, Israel, Thailand, Turkey, Russian Federation, United Kingdom, Taiwan, Philippines, India, Chile, Finland, Greece, Sl... and more
-
PfizerCompletedCarcinoma, Pancreatic DuctalUnited States, Netherlands, Canada, Hungary, Spain, United Kingdom, France, Austria, Belgium, Germany, Ireland, Korea, Republic of, Russian Federation, Sweden, South Africa, Italy, Singapore, Taiwan, Australia, India, Argentina, J... and more
-
AstraZenecaCompletedLocally Advanced Cervical CancerUnited States, Taiwan, Korea, Republic of, Brazil, Hungary, India, Japan, Mexico, Peru, Philippines, Poland, Russian Federation, China, Chile, South Africa
-
Novartis PharmaceuticalsRecruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationItaly, Spain, United States, France, Thailand, Malaysia, China, Germany, India, Turkey, Belgium, Argentina, Bulgaria, Netherlands, Hungary, Greece, Portugal, Austria, Singapore, Brazil, United Kingdom
-
AstraZenecaRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaSpain, United States, Italy, Korea, Republic of, United Kingdom, Vietnam, France, Japan, Brazil, India, Thailand, Germany, Canada, Turkey, Malaysia, Taiwan, Belgium, Austria, Hungary
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, United States, Germany, Italy, Poland, Belgium, Mexico, Turkey, Spain, France, Canada, Taiwan, Brazil, Austria, Hong Kong, India, Japan, Netherlands, Denmark
-
AstraZenecaGynecologic Oncology Group Foundation; European Network for Gynaecological...RecruitingLocally Advanced Cervical CancerSpain, Denmark, Italy, Korea, Republic of, Japan, Peru, China, Brazil, Taiwan, United States, Canada, Turkey, India, Poland, Mexico, Puerto Rico, Norway
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Argentina, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom